| Views | |
|---|---|
| Development of a transcutaneous form of desloratadine | 21 |
| October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| Development of a transcutaneous form of desloratadine | 4 | 0 | 4 | 3 | 0 | 0 | 1 |
| Views | |
|---|---|
| Ageev_Development_24.pdf | 27 |
| Views | |
|---|---|
| United States | 7 |
| EU | 3 |
| Germany | 2 |
| Canada | 1 |
| Jordan | 1 |
| Russia | 1 |
| Views | |
|---|---|
| Mountain View | 3 |
| Palo Alto | 2 |
| Amman | 1 |
| Dearborn | 1 |
| Mytishchi | 1 |
| Ottawa | 1 |
| Sacramento | 1 |